Chandigarh, July 27: Marking World Hepatitis Day, Paras Health highlighted the urgent need for early screening and greater public awareness around hepatitis and liver health. The hospital’s Department of Gastroenterology and Hepatology is actively working to improve diagnosis and treatment outcomes through advanced technologies and expert-led care.
“Hepatitis often progresses silently and may only be detected once severe damage like cirrhosis or liver failure sets in. Timely testing is critical to prevent long-term complications,” said Dr Rakesh Kochhar, Director – Gastroenterology, Paras Health. He added that the hospital uses advanced diagnostic tools like Fibroscan, liver function tests, endoscopy, colonoscopy, and liver biopsy for early detection and effective management.
Hepatitis—caused by viruses such as Hepatitis B and C, alcohol use, long-term medication, or metabolic disorders—is increasingly becoming a public health concern in India. Doctors at Paras have also cautioned against the rising cases linked to some herbal and ayurvedic supplements.
According to WHO’s 2024 report, India has the highest global burden of viral hepatitis, with nearly 40 million people living with chronic Hepatitis B and 6–12 million with Hepatitis C. Yet, testing and treatment remain limited—less than 3% of Hepatitis B patients are diagnosed, and treatment rates for Hepatitis C are below 20% in many areas, including tier-II cities.
Paras Health is preparing to launch liver transplant services soon, with successful cases already conducted at its Gurugram centre. With a focus on prevention, timely care, and public education, the hospital continues to expand its specialised services for liver and digestive health in the region.
